Tobramycin

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

21 Suppliers, 14 USDMF, 6 CEP/COS, 1 JDMF, 12 KDMF, 10 NDC API, 9 Listed Suppliers

DEVELOPMENTS

6 Drug(s) in Development

6 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Forms

138 Dossiers, 36 FDA Orange Book, 55 Europe, 3 Canada, 9 Australia, 7 South Africa, 28 Listed Dossiers

DRUG PRODUCT COMPOSITION

POWDER;INHALATION - 28MG, SOLUTION/DROPS;OPHTHALMIC - 0.3%, OINTMENT;OPHTHALMIC - 0.3%, SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3%, OINTMENT;OPHTHALMIC - 0.1%;0.3%, SOLUTION;INHALATION - 300MG/5ML, SUSPENSION/DROPS;OPHTHALMIC - 0.05%;0.3%

RELATED EXCIPIENT COMPANIES

Suppliers, 6 Actylis, 3 Finar, 2 Nanjing Well Pharmaceutical, 1 Microlex e.U, 1 Rochem International Inc, 1 Gangwal Healthcare, 1 Pharm-RX Chemical, 1 Nippon Fine Chemical, 1 BASF, 1 Curia

EXCIPIENTS BY APPLICATIONS

8 Parenteral, 4 Solubilizers, 4 Thickeners and Stabilizers, 2 Film Formers & Plasticizers, 2 Surfactant & Foaming Agents, 2 Topical, 2 Fillers, Diluents & Binders, 1 Dry Powder Inhalation, 1 API Stability Enhancers, 1 Emulsifying Agents

GLOBAL SALES INFORMATION

56 US Medicaid Prescriptions, 40 Finished Drug Prices

MARKET PLACE

27 APIs, 6 DOSSIERS // FDF

PATENTS

10 US Patents, 3 Health Canada Patents

ANALYTICAL SOLUTION(s)

4 EDQM Standards, 1 USP Standards, 2 Other Ref. Standards

DIGITAL CONTENT

3 Data Compilation & Company Tracker #PharmaFlow, 34 News

Information, Expiry & Status of Health Canada Patents covering Tobramycin.

Tobramycin

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

21 Suppliers

14 USDMF

6 CEP/COS

1 JDMF

12 KDMF

10 NDC API

9 Listed Suppliers

DEVELOPMENTS

6 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

DOSSIERs // Finished Dosage Forms

138 Dossiers

36 FDA Orange Book

55 Europe

3 Canada

9 Australia

7 South Africa

28 Listed Dossiers

DRUG PRODUCT COMPOSITION

POWDER;INHALATION - 28MG

SOLUTION/DROPS;OPHTHALMIC - 0.3%

OINTMENT;OPHTHALMIC - 0.3%

SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3%

OINTMENT;OPHTHALMIC - 0.1%;0.3%

SOLUTION;INHALATION - 300MG/5ML

SUSPENSION/DROPS;OPHTHALMIC - 0.05%;0.3%

RELATED EXCIPIENT COMPANIES

Suppliers

6 Actylis

3 Finar

2 Nanjing Well Pharmaceutical

1 Microlex e.U

1 Rochem International Inc

1 Gangwal Healthcare

1 Pharm-RX Chemical

1 Nippon Fine Chemical

1 BASF

1 Curia

EXCIPIENTS BY APPLICATIONS

8 Parenteral

4 Solubilizers

4 Thickeners and Stabilizers

2 Film Formers & Plasticizers

2 Surfactant & Foaming Agents

2 Topical

2 Fillers, Diluents & Binders

1 Dry Powder Inhalation

1 API Stability Enhancers

1 Emulsifying Agents

GLOBAL SALES INFORMATION

56 US Medicaid Prescriptions

40 Finished Drug Prices

MARKET PLACE

27 APIs

6 DOSSIERS // FDF

PATENTS

10 US Patents

3 Health Canada Patents

ANALYTICAL SOLUTION(s)

4 EDQM Standards

1 USP Standards

2 Other Ref. Standards

DIGITAL CONTENT

3 Data Compilation & Company Tracker #PharmaFlow

34 News

0.30%

Solution

Human

2021-06-26

2009-06-01